Anna Kaltenboeck, MA
Program Director / Senior Health Economist
Anna Kaltenboeck, MA is the Senior Health Economist and Program Director for the Center for Health Policy and Outcomes and the Drug Pricing Lab at Memorial Sloan Kettering Cancer Center. She focuses on the development and application of reimbursement methods for prescription drugs that reduce distortionary incentives in the supply chain and encourage pricing of treatments based on their value. Her work centers on developing an unbiased evidence base that characterizes the effect of federal policies on coverage and reimbursement decisions for branded specialty drugs and cell and gene therapies and identifying opportunities for policy changes that encourage affordability and access while maintaining incentives for innovation. The scope of her work spans the US, European Union 5, and emerging economies. Her current research interests include global comparisons of reimbursement policy and supply chain regulation, game theory in innovation decisions, and the effect of market concentration on pricing decisions. Ms. Kaltenboeck’s research and policy work is informed by her experience as a consultant for pharmaceutical clients. Prior to joining MSKCC, Ms. Kaltenboeck spent 10 years working for Analysis Group and IMS Consulting Group, where she conducted health economies and outcomes research and developing pricing and market access strategies for pharmaceutical and diagnostics products. She has published numerous articles in peer-reviewed journals and other press, including JAMA, Morning Consult, and STAT News. She speaks frequently on the topics of value-based pricing, economics of the supply chain, and reimbursement models. Ms. Kaltenboeck holds a bachelor’s and master’s degree in economics from Tufts University.